144 related articles for article (PubMed ID: 12376300)
41. [Changes of serum soluble tumor necrosis factor receptor I in patients with rheumatic fever].
Chen CY; Yang ZC; Lian NW
Hunan Yi Ke Da Xue Xue Bao; 2001 Dec; 26(6):571-2. PubMed ID: 12536547
[TBL] [Abstract][Full Text] [Related]
42. Serum alpha-fetoprotein level per tumor volume reflects prognosis in patients with hepatocellular carcinoma after curative hepatectomy.
Furihata T; Sawada T; Kita J; Iso Y; Kato M; Rokkaku K; Shimoda M; Kubota K
Hepatogastroenterology; 2008; 55(86-87):1705-9. PubMed ID: 19102374
[TBL] [Abstract][Full Text] [Related]
43. Possible contribution of serum activin A and IGF-1 in the development of hepatocellular carcinoma in Egyptian patients suffering from combined hepatitis C virus infection and hepatic schistosomiasis.
Elsammak MY; Amin GM; Khalil GM; Ragab WS; Abaza MM
Clin Biochem; 2006 Jun; 39(6):623-9. PubMed ID: 16624274
[TBL] [Abstract][Full Text] [Related]
44. Comparison between soluble tumor necrosis factor receptors and CA125 in peritoneal fluids as a marker for epithelial ovarian cancer.
Onsrud M; Shabana A; Austgulen R; Nustad K
Gynecol Oncol; 1995 May; 57(2):183-7. PubMed ID: 7729731
[TBL] [Abstract][Full Text] [Related]
45. [Monocyte tumor necrosis factor and tumor necrosis factor receptor expression in patients with alcoholic liver cirrhosis].
He S; Huang H
Zhonghua Nei Ke Za Zhi; 1997 Aug; 36(8):526-8. PubMed ID: 10436957
[TBL] [Abstract][Full Text] [Related]
46. Significance of the serum brain-derived neurotrophic factor and platelets in hepatocellular carcinoma.
Yang ZF; Ho DW; Lau CK; Tam KH; Lam CT; Yu WC; Poon RT; Fan ST
Oncol Rep; 2006 Dec; 16(6):1237-43. PubMed ID: 17089044
[TBL] [Abstract][Full Text] [Related]
47. Elevated serum levels of the type I and type II receptors for tumor necrosis factor-alpha as predictive factors for ARF in patients with septic shock.
Iglesias J; Marik PE; Levine JS;
Am J Kidney Dis; 2003 Jan; 41(1):62-75. PubMed ID: 12500222
[TBL] [Abstract][Full Text] [Related]
48. Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis.
Glossop JR; Dawes PT; Nixon NB; Mattey DL
Arthritis Res Ther; 2005; 7(6):R1227-34. PubMed ID: 16277675
[TBL] [Abstract][Full Text] [Related]
49. Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study.
Mazziotti G; Sorvillo F; Morisco F; Carbone A; Rotondi M; Stornaiuolo G; Precone DF; Cioffi M; Gaeta GB; Caporaso N; Carella C
Cancer; 2002 Dec; 95(12):2539-45. PubMed ID: 12467068
[TBL] [Abstract][Full Text] [Related]
50. The predictive ability of serum alpha-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance.
Huo TI; Hsia CY; Chu CJ; Huang YH; Lui WY; Wu JC; Lee PC; Chi CW; Lee SD
J Surg Oncol; 2007 Jun; 95(8):645-51. PubMed ID: 17530668
[TBL] [Abstract][Full Text] [Related]
51. Significance of the serum level of soluble E-cadherin in patients with HCC.
Soyama A; Eguchi S; Takatsuki M; Kawashita Y; Hidaka M; Tokai H; Nagayoshi S; Mochizuki S; Matsumoto S; Hamasaki K; Tajima Y; Kanematsu T
Hepatogastroenterology; 2008; 55(85):1390-3. PubMed ID: 18795696
[TBL] [Abstract][Full Text] [Related]
52. Correlation of serum soluble TNF-alpha receptors I and II levels with disease activity in patients with ulcerative colitis.
Hanai H; Watanabe F; Yamada M; Sato Y; Takeuchi K; Iida T; Tozawa K; Tanaka T; Maruyama Y; Matsushita I; Iwaoka Y; Saniabadi A
Am J Gastroenterol; 2004 Aug; 99(8):1532-8. PubMed ID: 15307873
[TBL] [Abstract][Full Text] [Related]
53. Clinical evaluation of proinflammatory cytokine inhibitors (sTNFR I, sTNFR II, IL-1 ra), anti-inflammatory cytokines (IL-10, IL-13) and activation of neutrophils after burn-induced inflammation.
Sikora JP; Chlebna-Sokół D; Andrzejewska E; Chrul S; Polakowska E; Wysocka A; Sikora A
Scand J Immunol; 2008 Aug; 68(2):145-52. PubMed ID: 18702744
[TBL] [Abstract][Full Text] [Related]
54. Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma.
Poon RT; Lau CP; Cheung ST; Yu WC; Fan ST
Cancer Res; 2003 Jun; 63(12):3121-6. PubMed ID: 12810638
[TBL] [Abstract][Full Text] [Related]
55. Plasma levels of tumor necrosis factor alpha and soluble tumor necrosis factor receptors in patients with narcolepsy.
Himmerich H; Beitinger PA; Fulda S; Wehrle R; Linseisen J; Wolfram G; Himmerich S; Gedrich K; Wetter TC; Pollmächer T
Arch Intern Med; 2006 Sep; 166(16):1739-43. PubMed ID: 16983052
[TBL] [Abstract][Full Text] [Related]
56. Detecting AFP mRNA in peripheral blood of the patients with hepatocellular carcinoma, liver cirrhosis and hepatitis.
Yao F; Guo JM; Xu CF; Lou YL; Xiao BX; Zhou WH; Chen J; Hu YR; Liu Z; Hong GF
Clin Chim Acta; 2005 Nov; 361(1-2):119-27. PubMed ID: 15993394
[TBL] [Abstract][Full Text] [Related]
57. Changes of cytokines in cirrhosis patients with advanced hepatocellular carcinoma treated by intra-arterial chemotherapy.
Nagai H; Miyaki D; Matsui T; Kanayama M; Higami K; Momiyama K; Ikehara T; Watanabe M; Sumino Y; Miki K
Cancer Chemother Pharmacol; 2008 Jul; 62(2):271-6. PubMed ID: 17899083
[TBL] [Abstract][Full Text] [Related]
58. Serum levels of p55 and p75 soluble TNF receptors in adult acute leukaemia at diagnosis: correlation with clinical and biological features and outcome.
Vinante F; Rigo A; Tecchio C; Morosato L; Nadali G; Ricetti MM; Krampera M; Zanolin E; Locatelli F; Gallati H; Chilosi M; Pizzolo G
Br J Haematol; 1998 Sep; 102(4):1025-34. PubMed ID: 9734654
[TBL] [Abstract][Full Text] [Related]
59. Association between cigarette smoking and release of tumour necrosis factor alpha and its soluble receptors by peripheral blood mononuclear cells in patients with rheumatoid arthritis.
Glossop JR; Dawes PT; Mattey DL
Rheumatology (Oxford); 2006 Oct; 45(10):1223-9. PubMed ID: 16585133
[TBL] [Abstract][Full Text] [Related]
60. Significance of circulating endothelial progenitor cells in hepatocellular carcinoma.
Ho JW; Pang RW; Lau C; Sun CK; Yu WC; Fan ST; Poon RT
Hepatology; 2006 Oct; 44(4):836-43. PubMed ID: 17006919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
